Surgical progress and understanding in the treatment of the melanoma epidemic

American Journal of Surgery

Volumn 178, Issue 6, 1999, Pages 443-448

  Polk Jr , Hiram C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; MELPHALAN;

AGE; BLEEDING; CANCER INVASION; CHEMOTHERAPY; HISTOPATHOLOGY; HUMAN; HYPERTHERMIA; LIMB PERFUSION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MELANOMA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; SEX DIFFERENCE; SHORT SURVEY; SURGICAL TECHNIQUE; THICKNESS; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR GROWTH; ULCER; UNITED STATES;

EID: 0343775772     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00232-9     Document Type: Article

References (38)

1. Organ C.H. Jr. The general surgeon's image in a modern society how does a surgical editor see it? Am J Surg. 168:1994;293-294.
2. Organ C.H. Jr, Kosiba M.M. A Century of Black Surgeons The USA Experience . vols I and II:1987;Transcript Press, Norman, OK.
3. Davis N.C. Cutaneous melanoma the Queensland experience . Curr Probl Surg. 13:1976;1-63.
4. Rigel D.S. Malignant melanoma perspectives on incidence and its effects on awareness, diagnosis, and treatment . CA Cancer J Clin. 46:1996;195-198.
5. Friedman R.J., Rigel D.S., Kopf A.W. Early detection of malignant melanoma the role of physician examination and self-examination of the skin . CA Cancer J Clin. 35:1985;130-151.
6. Urist M.M. Surgical management of primary cutaneous melanoma. CA Cancer J Clin. 46:1996;217-224.
7. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 172:1970;902-908.
8. Kemeny M.M., Busch E., Stewart A.K., Menck H.R. Superior survival of young women with malignant melanoma. Am J Surg. 175:1998;437-444.
9. Shaw H.M., Thompson J.F. Superior survival of young women with malignant melanoma [Letter]. Am J Surg. 177:1999;176.
10. McCarthy WH, ed. Melanoma and skin cancer. Proceedings of the International Cancer Conference; March 13-17, 1972; Sydney, Australia.
11. Milton G.W. Malignant Melanoma of the Skin and Mucous Membrane. 1977;Churchill Livingstone, New York.
12. Walker M.J., Ronan S.G., Han M.C., et al. Interrelationship between histopathologic characteristics of melanoma and estrogen receptor status. Cancer. 68:1991;184-188.
13. Reintgen D.S., McCarty K.S. Jr, Vollmer R., et al. Malignant melanoma and pregnancy. Cancer. 55:1985;1340-1344.
14. Milton G.W. Melanoma in pregnancy; occult primary melanoma; melanoma in children; spontaneous regression. Milton G.W. Malignant Melanoma of the Skin and Mucous Membrane. 1977;152-156 Churchill Livingstone, New York.
15. Epstein E., Bragg K., Linden G. Biopsy and prognosis of malignant melanoma. JAMA. 208:1969;1369-1371.
16. Lees V.C., Briggs J.C. Effect of initial biopsy procedure on prognosis in Stage 1 invasive cutaneous malignant melanoma review of 1086 patients . Br J Surg. 78:1991;1108-1110.
17. Aitken D.R., Clausen K., Klein J.P., James A.G. The extent of primary melanoma excision a re-evaluation: how wide is wide? Ann Surg. 198:1983;634-641.
18. Fraser D.G., Bull J.G. Jr, Dunphy J.E. Malignant melanoma and coexisting malignant neoplasms. Am J Surg. 122:1971;169-174.
19. Veronesi U., Adamus J., Bandiera D.C., et al. Inefficacy of immediate node dissection in Stage I melanoma. N Engl J Med. 297:1977;627-630.
20. Polk H.C. Jr, Linn B.S. Selective regional lymphadenectomy for melanoma a mathematical aid to clinical judgment . Ann Surg. 174:1971;402-413.
21. Bland K.I., Klamer T.W., Polk H.C. Jr, Knutson C.O. Isolated regional lymph node dissection morbidity, mortality and economic considerations . Ann Surg. 193:1981;372-376.
22. Spratt J.S. Jr, Shieber W., Dillard B.M. Anatomy and Surgical Technique of Groin Dissection. 1965;CV Mosby, St. Louis.
23. Fee H.J., Robinson D.S., Sample W.F., et al. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma a preliminary study . Surgery. 84:1978;626-632.
24. McMasters K.M., Giuliano A.E., Ross M.I., et al. Sentinel lymph node biopsy for breast cancer not yet the standard of care . N Engl J Med. 339:1998;990-995.
25. Giuliano A.E., Moseley H.S., Morton D.L. Clinical aspects of unknown primary melanoma. Ann Surg. 191:1980;98-104.
26. Balch C.M., Soong S.J., Bartolucci A.A., et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age or younger. Ann Surg. 224:1996;255-266.
27. Wanebo H.J., Fortner J.G., Woodruff J., et al. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion use of the combined microstage technique (Clark-Breslow) . Ann Surg. 182:1975;302-315.
28. Shivers S.C., Wang X., Li W., Joseph E., et al. Molecular staging of malignant melanoma correlation with clinical outcome . JAMA. 280:1998;1410-1415.
29. Creech O. Jr, Krementz E.T., Ryan R.F., et al. Chemotherapy of cancer regional perfusion utilizing an extracorporeal circuit . Ann Surg. 148:1958;616-632.
30. Krementz E.T., Ryan R.F., Carter R.D., et al. Hyperthermic regional perfusion for melanoma of the limbs. Balch C.M., Milton G.W. Cutaneous Melanoma Clinical Management and Treatment Results Worldwide . 1985;171-195 JB Lippincott, Philadelphia.
31. Schwemmle K., Aigner K. Vascular Perfusion in Cancer. 1983;Springer-Verlag, New York.
32. Stehlin J.S., Giovanella B.C., deIpolyi P.D., et al. Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet. 140:1975;339-348.
33. Ghussen F., Nagel K., Groth W., et al. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg. 200:1984;764-768.
34. Edwards M.J., Soong S.J., Boddie A.W., et al. Isolated limb perfusion for localized melanoma of the extremity. Arch Surg. 125:1990;319-321.
35. Taber S.W., Polk H.C. Jr. Mortality, major amputation rates, and leukopenia after isolated limb perfusion with phenylalanine mustard for the treatment of melanoma [Review]. Ann Surg Oncol. 4:1997;440-445.
36. Vrouenraets B.C. Toxicity and Morbidity of Isolated Limb Perfusion. 1997;Thesis Publishers, Amsterdam.
37. Kirkwood J.M., Strawderman M.H., Ernstoff M.S., et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma the Eastern Cooperative Oncology Group Trial EST 1684 . J Clin Oncol. 14:1996;7-17.
38. Kersey P.A., Iscoe N.A., Gapski J.A., et al. The value of staging and serial follow-up investigations in patients with completely resected, primary cutaneous malignant melanoma. Br J Surg. 72:1985;614-617.